Table 1 Baseline characteristics in the groups
Characteristics | HC | Untreated CHB | CHB treated with Peg-IFN-α | P value |
|---|---|---|---|---|
Number(n) | 26 | 40 | 56 | |
Age(year) | 33.35 ± 7.990 | 41.1 ± 9.934 | 46(38.25,51.00) | 0.0962 |
Gender(male/female) | 14/12 | 17/23 | 36/20 | |
HBsAg (log10 IU/mL) | UD | 3.138(2.957,3.347) | 2.954(1.639,3.349) | 0.0174 |
HBV DNA (log10 IU/mL) | UD | 1.699(1.699,2.835) | 1.699(1.699,3.000) | 0.8152 |
ALT(IU/L) | 25.12 ± 7.506 | 19(13.25,38.75) | 25.5(18.00,37.00) | 0.1910 |
AST(IU/L) | 22.5 ± 5.616 | 24(20.00,33.75) | 23.5(19.00,30.75) | 0.5925 |
WBC(*10^9 /mL) | 5.745 (4.408,7.158) | 4.209 ± 1.315 | 4.704 ± 1.343 | 0.0957 |
Tbil(umol/L) | 11.75(6.575,15.68) | 10.45(8.300,14.55) | 10.65(8.200,14.05) | 0.9484 |
PLT(*10^9/L) | 202.3 ± 50.45 | 168.7 ± 65.10 | 160.0 ± 46.73 | 0.4536 |